There is capital sitting on the sidelines, but founders and CEOs should realize that investors are digging into their due diligence. The “wow” factor and potential size of the medtech market matter much less now than solid fundamentals.
To achieve success, a medical device startup must build a sophisticated data architecture specifically designed to deliver maximum value for its customers’ use cases. However, it’s extremely difficult to build such an architecture—especially given early-stage budget constraints. That’s why startups must wisely synch their data architecture spending with their funding rounds.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Although transactions were down, they exceeded more than $450 million last month.
Eighty medtech transactions in Europe came in at a value of approximately $627.5 million.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
Overall activity in deals jumped 11% in North America.
Ernst & Young’s annual Pulse of the Industry report reveals decreasing global revenue and financing in the medtech industry.